Nanochon, a cultivate(MD) portfolio company, has launched a new podcast titled “ChonChats,” hosted by Benjamin Holmes and Rachel Offenburg. The inaugural episode features R. Sean Churchill, MD, MBA, discussing:
Dr. Sean Churchill, MBA Joins Nanochon’s ChonChats Read More »
Virtual Incision, a cultivate(MD) portfolio company, has announced plans to explore the use of Nvidia Isaac for Healthcare to advance next-generation surgical robotics. The company intends to harness the digital twin framework and robotic learning tools provided by Nvidia. This integration could enable the creation of highly detailed virtual environments to simulate complex surgical procedures
Virtual Incision to Explore Nvidia AI for Surgical Robotics Read More »
Grand Rapids, MI – March 10, 2025 – Shoulder Innovations, a cultivate(MD) portfolio company, and a leader in shoulder replacement technology, today announced the closing of a $40 million Series E equity financing round. The financing was led by existing investor U.S. Venture Partners (USVP), with support from additional existing investors including Gilde Healthcare Partners, Gilmartin Capital,
Shoulder Innovations Announces Closing of $40 Million Series E Equity Financing Read More »
Strados Labs, a cultivate(MD) portfolio company announced a new collaboration with Beth Israel Deaconess Medical Center (BIDMC). The upcoming study will evaluate the use of Strados Labs’ RESP® Biosensor, an FDA-cleared wearable stethoscope technology, for the early detection of pulmonary edema in critically ill patients on mechanical ventilation (MV). This pilot study is scheduled to
We’re excited to announce that Dr. Ryan Roeder from HAPPE Spine will be delivering a scientific presentation on “Next Generation PEEK Interbody Fusion Devices: Scientific Foundations and Clinical Outcomes” Thursday, August 15, 2024 at 7 PM CT. This pre-meeting webinar is part of the upcoming North American Spine Society (NASS) conference, and it’s an incredible
Dr. Ryan Roeder Presenting at NASS Webinar Read More »
Grand Rapids, MI – August 12, 2024 – cultivate(MD), a leading medical device venture capital company announced today its participation in the successful Series A extension round of Prana Thoracic, a Houston-based medtech startup. The round, which was oversubscribed by 30%, secured an additional $3 million, bringing Prana Thoracic’s total funding to $9 million. This achievement underscores the
cultivate(MD) Invests in Prana Thoracic Read More »
Grand Rapids, MI – July 24, 2024 – Shoulder Innovations, a cultivate(MD) portfolio company and leader in shoulder replacement technology, today announced the United States Patent and Trademark Office (USPTO) has granted nine new patents over the past 18 months that significantly expand the Company’s intellectual property portfolio. The newly granted patents cover key areas within
cultivate(MD) is excited announce a significant milestone achieved by one of our portfolio companies, SentiAR. The Valley Hospital in Ridgewood, New Jersey, has become the first in the state and one of the pioneers in the United States to treat a patient using SentiAR’s FDA-cleared holographic cardiac ablation visualization platform, CommandEP. This groundbreaking procedure marks the first instance
New Jersey’s First Holographic Cardiac Ablation Guided by SentiAR’s CommandEP Read More »
Grand Rapids, Mich., June 13, 2024 — Sterile Processing Express (SPDx) announced today that it has achieved a major milestone in its healthcare business development. SPDx has received an Advanced Sterile Processing Certification from DNV GL, a global independent certification, assurance, and risk management provider. “Our team has diligently built a quality management system to provide the
Grand Rapids, MI., February 27, 2024 – Virtual Incision, a cultivate(MD) portfolio company, has been granted marketing authorization of the MIRA™ Surgical System (MIRA) from the FDA. This marks a significant milestone as MIRA becomes the first miniaturized robotic-assisted surgery device in the world approved for adult colectomy procedures. The device was submitted via the FDA’s De Novo
